{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:22:26Z","timestamp":1770996146751,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54HD090254"],"award-info":[{"award-number":["U54HD090254"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["1R43AR073547-01"],"award-info":[{"award-number":["1R43AR073547-01"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001625","name":"Foundation to Eradicate Duchenne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["U54 RR019497"],"award-info":[{"award-number":["U54 RR019497"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001703","name":"Cure JM Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.steroids.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T22:42:22Z","timestamp":1540075342000},"page":"159-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-6350","authenticated-orcid":false,"given":"Laurie S.","family":"Conklin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Pachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemang","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shefa","family":"Tawalbeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse M.","family":"Damsker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Monach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yetrib","family":"Hathout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanneboyina","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"McAlear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.steroids.2018.10.008_b0005","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/03007995.2018.1474090","article-title":"Quantitative characterization of the relationship between levels of extended corticosteroid use and related adverse events in a US population","volume":"34","author":"Bradford Rice","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.steroids.2018.10.008_b0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000442323","article-title":"Overview of the pathogenesis of ANCA-associated vasculitis","volume":"1","author":"Xiao","year":"2016","journal-title":"Kidney Dis."},{"issue":"9","key":"10.1016\/j.steroids.2018.10.008_b0015","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.steroids.2018.10.008_b0020","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/art.21117","article-title":"Damage caused by Wegener\u2019s granulomatosis and its treatment: prospective data from the Wegener\u2019s Granulomatosis Etanercept Trial (WGET)","volume":"52","author":"Seo","year":"2005","journal-title":"Arthritis"},{"issue":"3","key":"10.1016\/j.steroids.2018.10.008_b0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/rheumatology\/keu366","article-title":"Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European vasculitis study group trials","volume":"54","author":"Robson","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.steroids.2018.10.008_b0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00296-017-3855-6","article-title":"Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"38","author":"Robson","year":"2018","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.steroids.2018.10.008_b0035","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal Diseases Registry","volume":"49","author":"Mendez","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.steroids.2018.10.008_b0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpeds.2017.12.053","article-title":"Advances in juvenile dermatomyositis: myositis specific antibodies aid in understanding disease heterogeneity","volume":"195","author":"Pachman","year":"2018","journal-title":"J. Pediatr."},{"issue":"11","key":"10.1016\/j.steroids.2018.10.008_b0045","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.39753","article-title":"Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.steroids.2018.10.008_b0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12969-017-0174-0","article-title":"Biologic therapies for refractory juvenile dermatomyositis: five yearsof experience of the childhood arthritis and rheumatology research alliance in North America","volume":"15","author":"Spencer","year":"2017","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.steroids.2018.10.008_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2018.03.016","article-title":"Medications received by patients with juvenile dermatomyositis","author":"Kishi","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.steroids.2018.10.008_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1472-6882-8-25","article-title":"How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies","volume":"8","author":"Rouster-Stevens","year":"2008","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.steroids.2018.10.008_b0065","doi-asserted-by":"crossref","first-page":"31727","DOI":"10.1038\/srep31727","article-title":"Serum pharmacodynamic biomarkers for chronic corticosteroids treatment of children","volume":"6","author":"Hathout","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.steroids.2018.10.008_b0070","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.49","article-title":"Identification of pathway \u2013 specific serum biomarkers of response to glucocorticoid and infliximab treatment in children with inflammatory bowel disease","volume":"7","author":"Heier","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"1","key":"10.1016\/j.steroids.2018.10.008_b0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.10924","article-title":"Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence","volume":"49","author":"Bode","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.steroids.2018.10.008_b0080","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/acr.20280","volume":"62","author":"Ruperto","year":"2016","journal-title":"Arthritis Care Res."},{"issue":"5","key":"10.1016\/j.steroids.2018.10.008_b0085","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.40060","volume":"69","author":"Rider","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.steroids.2018.10.008_b0090","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/s41598-018-26640-w","article-title":"Stability and reproducibility of proteomic profiles measured with an aptamer-based platform","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.steroids.2018.10.008_b0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: a general population perspective","volume":"65","author":"Overman","year":"2013","journal-title":"Arthritis Care Res."},{"issue":"2","key":"10.1016\/j.steroids.2018.10.008_b0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1740774517751118","article-title":"Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disorders","volume":"15","author":"Peay","year":"2018","journal-title":"Clin. Trials"},{"issue":"1","key":"10.1016\/j.steroids.2018.10.008_b0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MPG.0000000000001024","article-title":"Use of placebo in pediatric inflammatory bowel diseases: a position paper from ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network","volume":"62","author":"Turner","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.steroids.2018.10.008_b0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.steroids.2018.02.010","article-title":"Phase 1 trial of vamorolone, a first-in-class steroid, shows improvement in side effects via biomarkers bridged to clinical outcomes","volume":"134","author":"Hoffman","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.10.008_b0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phrs.2018.09.007","article-title":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","volume":"136","author":"Conklin","year":"2018","journal-title":"Pharmacol. Res."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X18301958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X18301958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:03:43Z","timestamp":1758535423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X18301958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":23,"alternative-id":["S0039128X18301958"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2018.10.008","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}